ctrl K

Price Alert

Lineage Cell Therapeutics... (LCTX)

AMEX: LCTX · Real-Time Price · USD

1.19

0.17 (16.67%)

At close: Aug 15, 2025, 3:59 PM

1.21

1.68%

After-hours: Aug 15, 2025, 06:47 PM EDT

Lineage Cell Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	45.79M	35.44M	11.36M	55.74M
Short-Term Investments	2.02M	50K	46.52M	2.62M
Long-Term Investments	n/a	550K	581K	535K
Other Long-Term Assets	614K	27K	627K	630K
Receivables	638K	745K	297K	50.84M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.55M	22.5K	1.83M	n/a
Total Current Assets	51M	38.44M	60M	111.55M
Property-Plant & Equipment	4.39M	4.77M	5.67M	4.87M
Goodwill & Intangibles	57.21M	57.23M	57.36M	57.49M
Total Long-Term Assets	62.22M	62.58M	63.66M	63M
Total Assets	113.22M	101.02M	123.66M	174.54M
Account Payables	1.17M	2.05M	2.39M	3.54M
Deferred Revenue	7.39M	10.81M	9.42M	18.12M
Short-Term Debt	n/a	n/a	n/a	831K
Other Current Liabilities	n/a	n/a	3.83M	21.63M
Total Current Liabilities	13.98M	17.96M	18.98M	47.12M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.16M	18.97M	2K	30K
Total Long-Term Liabilities	22.23M	21.04M	32.75M	36.53M
Total Liabilities	36.21M	39M	51.73M	83.65M
Total Debt	2.51M	2.95M	3.9M	2.8M
Common Stock	484.72M	451.34M	440.28M	434.53M
Retained Earnings	-403.46M	-384.86M	-363.37M	-337.1M
Comprehensive Income	-2.88M	-3.07M	-3.57M	-5.21M
Shareholders Equity	78.38M	63.42M	73.34M	92.22M
Total Investments	2.02M	50K	46.52M	2.62M